Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

gavel

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle

September 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

Feature
nhs_trees_brett_wells_source_web

NHS needs emergency £350 million to survive winter

September 4, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …

News
entrance_takeda_i020_v1

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017
Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

News
joseph_jimenez

Novartis CEO Jimenez announces retirement in 2018

September 4, 2017
Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

News

R&D tax credits: A novel approach to supply chain funding

September 1, 2017
Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …

News
astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

News

NHS pumps £100m into GP recruitment as numbers plummet

September 1, 2017
Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …

News
genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017
Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature
lilly2_web

Lilly gets second shot at application for ‘blockbuster’ arthritis drug

August 31, 2017
Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical

Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …

News
teva

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017
Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …

News
novartis_hq_day

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …

News

Abbott issues patch for vulnerable heart devices

August 31, 2017
Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026